The American Journal of Managed Care29d
Resmetirom Reduces Liver Stiffness in MASH-Compensated Cirrhosis
2 “Patients with MASH who progress to cirrhosis face a 42 times higher risk of liver-related mortality, so there is an urgent need to improve care for this underserved population with no ...
The Victoria Advocate10d
AASLD Opens Call for Applications for Sites to Participate in TARGET-LD and the Cirrhosis Quality Collaborative (CQC Data Registry)
The study is grounded in longitudinal clinical care as a foundation for building prospective studies and includes participation in the AASLD Cirrhosis Quality Collaborative (CQC Registry).
Today's Dietitian4d
Weight-Loss Surgery May Lower Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity
The aim of the SPECCIAL (Surgical Procedures Eliminate Compensated Cirrhosis In Advancing Long-term) study was to examine the long-term outcomes of bariatric surgery on the risk of developing major ...
Nasdaq1mon
Madrigal Unveils Encouraging Two-Year Results For Rezdiffra In Compensated MASH Cirrhosis
The results from the MAESTRO-NAFLD-1 trial are a step forward in Madrigal's mission to improve care for patients with MASH cirrhosis, a condition that currently lacks FDA-approved treatments.